Dr. Ramakrishnan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
901 W Ben White Blvd
Austin, TX 78704Phone+1 512-816-8600Fax+1 512-816-6171
Summary
- Dr. Aravind Ramakrishnan is an oncologist in Austin, TX and is affiliated with multiple hospitals in the area, including UW Medicine/Harborview Medical Center, St. David's South Austin Medical Center, Methodist Hospital, and Seattle Cancer Care Alliance. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 16 years. He also speaks multiple languages, including Tamil. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hematopoietic stem cell transplantation.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2004 - 2006
Baylor College of MedicineResidency, Internal Medicine, 2001 - 2004
Rutgers Robert Wood Johnson Medical SchoolClass of 2001
Certifications & Licensure
WA State Medical License 2004 - 2027
TX State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Access Barriers to Anti-CD19+ CART-Cell Therapy for NHL Across a Community Transplant and Cellular Therapy Network.Minoo Battiwalla, Michael T Tees, Ian W Flinn, Jeremy Pantin, Jesus G Berdeja
Blood Advances. 2024-10-17 - Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital Setting.Minoo Battiwalla, Ju-Hsien Chao, Tonya Cox, Jose Carlos Cruz, William B Donnellan
Clinical Hematology International. 2024-01-01 - 34 citationsDual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma.Claire Roddie, Lazaros J Lekakis, Maria A V Marzolini, Aravind Ramakrishnan, Yiyun Zhang
Blood. 2023-05-18
Press Mentions
Sarah Cannon to Present Latest in Blood Cancer Research at the 62nd ASH Annual Meeting & ExpositionDecember 4th, 2020- Sarah Cannon to Present Latest Cancer Research Insights at ASCO®20 Virtual MeetingMay 28th, 2020
Outpatient Care for Bone Marrow Transplants a Recovery BlessingMarch 27th, 2016
Other Languages
- Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
